PCVX
Vaxcyte, Inc. - Common Stock (PCVX)
$92
About Vaxcyte, Inc. - Common Stock (PCVX)
Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.
Details
Daily high
$65.88
Daily low
$61.84
Price at open
$65.88
52 Week High
$90.75
52 Week Low
$40.14
Market cap
10.3B
Dividend yield
-
Volume
1.8M
Avg. volume
2.4M
P/E ratio
-8.52
Vaxcyte, Inc. - Common Stock News
Details
Daily high
$65.88
Daily low
$61.84
Price at open
$65.88
52 Week High
$90.75
52 Week Low
$40.14
Market cap
10.3B
Dividend yield
-
Volume
1.8M
Avg. volume
2.4M
P/E ratio
-8.52